Wed, Jan 28, 2026
Volume 19, Issue 6 (Nov-Dec 2025)
mljgoums 2025, 19(6): 1-4 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sheikh Sajjadieh M. Diagnostic value of polarized optical microscopy in pseudogout: A review of calcium pyrophosphate deposition disease in the clinical laboratory. mljgoums 2025; 19 (6) :1-4
URL: http://mlj.goums.ac.ir/article-1-1943-en.html
URL: http://mlj.goums.ac.ir/article-1-1943-en.html
Australian Institute of Medical and Clinical Scientists, Melbourne, Australia , mohammad_esfahan@yahoo.com
Abstract: (543 Views)
Background: Pseudogout, also known as calcium pyrophosphate deposition (CPPD) disease, is a common but often underdiagnosed crystal-induced arthropathy. It occurs when CPPD crystals deposit in articular cartilage and synovial fluid. Because its clinical manifestations often mimic gout or septic arthritis, accurate differentiation is essential for appropriate patient management. Recognition of the unique pathophysiology and crystal morphology of pseudogout is therefore critical for laboratory diagnosis.
Methods: This narrative review summarizes and integrates findings from selected, well-established sources to provide clinical and laboratory perspectives, highlight best practices, and identify areas requiring standardization. The existing evidence regarding the diagnostic application of polarized optical microscopy (POM) in pseudogout was evaluated. Key themes include the principles of POM, optimal specimen collection and handling, techniques for accurate crystal identification, and recommended laboratory workflow practices. Additionally, the review discusses factors that influence diagnostic accuracy, such as technician proficiency and the use of standardized microscopic evaluation protocols.
Results: The findings indicate that polarized light microscopy remains the gold standard for identifying CPPD crystals. Rhomboid-shaped crystals exhibiting weakly positive birefringence are characteristic of pseudogout and allow reliable differentiation from monosodium urate crystals observed in gout. Proper specimen preparation - particularly timely examination of fresh synovial fluid - and adherence to standardized microscopy practices significantly enhance diagnostic yield. In addition, targeted technician training in crystal recognition improves interobserver consistency and reduces misclassification.
Conclusion: Polarized light microscopy is an indispensable tool for the accurate laboratory diagnosis of pseudogout. Increasing awareness of crystal morphology, improving specimen-handling practices, and investing in consistent technician training can substantially enhance diagnostic accuracy. Standardizing the use of POM across clinical laboratories will support earlier detection and improved clinical management of pseudogout.
Methods: This narrative review summarizes and integrates findings from selected, well-established sources to provide clinical and laboratory perspectives, highlight best practices, and identify areas requiring standardization. The existing evidence regarding the diagnostic application of polarized optical microscopy (POM) in pseudogout was evaluated. Key themes include the principles of POM, optimal specimen collection and handling, techniques for accurate crystal identification, and recommended laboratory workflow practices. Additionally, the review discusses factors that influence diagnostic accuracy, such as technician proficiency and the use of standardized microscopic evaluation protocols.
Results: The findings indicate that polarized light microscopy remains the gold standard for identifying CPPD crystals. Rhomboid-shaped crystals exhibiting weakly positive birefringence are characteristic of pseudogout and allow reliable differentiation from monosodium urate crystals observed in gout. Proper specimen preparation - particularly timely examination of fresh synovial fluid - and adherence to standardized microscopy practices significantly enhance diagnostic yield. In addition, targeted technician training in crystal recognition improves interobserver consistency and reduces misclassification.
Conclusion: Polarized light microscopy is an indispensable tool for the accurate laboratory diagnosis of pseudogout. Increasing awareness of crystal morphology, improving specimen-handling practices, and investing in consistent technician training can substantially enhance diagnostic accuracy. Standardizing the use of POM across clinical laboratories will support earlier detection and improved clinical management of pseudogout.
Keywords: Pseudogout, Calcium Pyrophosphate Deposition Disease, Chondrocalcinosis, Crystal Arthropathies, Synovial Fluid, Birefringence, Polarized optical microscopy
Research Article: Review Article |
Subject:
Laboratory Sciences
Received: 2025/05/13 | Accepted: 2025/12/18 | Published: 2025/12/21 | ePublished: 2025/12/21
Received: 2025/05/13 | Accepted: 2025/12/18 | Published: 2025/12/21 | ePublished: 2025/12/21
References
1. Zhang W, Doherty M, Pascual E, Barskova V, Guerne P-A, Jansen TL, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011;70(4):571-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Rosales-Alexander JL, Balsalobre Aznar J, Magro-Checa C. Calcium pyrophosphate crystal deposition disease: diagnosis and treatment. Open Access Rheumatol. 2014;6:39-47. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Abhishek A, Doherty M. Pathophysiology of articular chondrocalcinosis-role of ANKH. Nat Rev Rheumatol. 2011;7(2):96-104. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237-41. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Pascual E, Sivera F, Andrés M. Synovial fluid analysis for crystals. Curr Opin Rheumatol. 2011;23(2):161-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Verbruggen G, Wittoek R, Vander Cruyssen B, Elewaut D. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double-blind, randomised trial on structure modification. Ann Rheum Dis. 2012;71(6):891–8. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Lumbreras B, Pascual E, Frasquet J, González-Salinas J, Rodríguez E, Hernández-Aguado I. Analysis for crystals in synovial fluid: training of the analysts results in high consistency. Ann Rheum Dis. 2005;64(4):612–5. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Ryan LM, McCarty DJ. Calcium pyrophosphate crystal deposition disease: pseudogout and articular chondrocalcinosis. In: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR, editors. Kelley & Firestein’s. Textbook of Rheumatology. 10th ed. Philadelphia: Elsevier; 2017. [View at Publisher]
9. Joshi A, Siva C. Magnesium disorders can cause calcium pyrophosphate deposition disease: a case report and literature review. Eur J Rheumatol. 2018;5(1):53–7. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Rosentha AK, Ryan LM. Clinical practice. Calcium pyrophosphate deposition disease. N Engl J Med. 2016;374(26):2575–84. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Schumacher HR. Crystal-induced arthritis: an overview. Am J Med. 1996;100(2A):46S-52S. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Sheikh Sajjadieh M, Ajami A, Haghshenas L. Estimation of sensitivity and specificity of antinuclear antibody by automated indirect immunofluorescence and enzyme-linked immunoassay. mljgoums. 2024;18(4):22-3. [View at Publisher] [DOI] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Contact us
Tel & Fax: (+98) 17-32450093
E-mail:
goums.ac.ir
yahoo.com